Browsing Tag

EDSIVO

Acer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering…

Eli Pacheco Oct 26, 2022 0

NEWTON, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a clinical stage pharmaceutical company focused on the acquisition, development and…

Health

Acer Therapeutics Announces Initiation of its Pivotal Phase 3 DiSCOVER Trial of…

Eli Pacheco Jun 28, 2022 0

NEWTON, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a clinical stage pharmaceutical company focused on the acquisition, development and…

Health

Acer Therapeutics Announces Agreement with FDA on Special Protocol Assessment for its…

Eli Pacheco May 9, 2022 0

NEWTON, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies…

Health

Acer Therapeutics’ EDSIVO™ (celiprolol) Granted FDA Breakthrough Therapy Designation…

Eli Pacheco Apr 4, 2022 0

NEWTON, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of…